Skip to content
‹ Back to IndustriesHealthcare

Exploring the Different COVID Tests

On this episode of HealthFirst Talks, host Grace Huang welcomes two medical expert guests to discuss the different COVID-19 tests, their efficacy, and what test to use in different scenarios. Those guests are Dr. Scott Cohen, Chief Medical Information Officer and Chief Performance Improvement Officer for Bassett Healthcare Network, and Dr. Fiona Collins, dentist and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from HealthFirst on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

On this episode of HealthFirst Talks, host Grace Huang welcomes two medical expert guests to discuss the different COVID-19 tests, their efficacy, and what test to use in different scenarios. Those guests are Dr. Scott Cohen, Chief Medical Information Officer and Chief Performance Improvement Officer for Bassett Healthcare Network, and Dr. Fiona Collins, dentist and international speaker and author.

Drs. Cohen and Collins explained the two types of COVID-19 tests: PCR tests and antigen tests. “There are two broad types of COVID-19 diagnostic tests. The antigen test takes the nasal fluid and looks for the presence of the antigen. If so, it’s positive. The PCR is looking for the presence of coronavirus RNA,” Dr. Cohen said.

Which is more accurate? Dr. Collins explained, “When looking at accuracy, diagnostic tests can be high sensitivity or high specificity. With high sensitivity, you have very few false negatives. With high specificity, very few false positives.”

The doctors agreed that false negatives were more concerning for COVID-19. With a false positive, the worst that could happen is isolation. A false negative could lead to spread.

When looking at the two tests, Dr. Collins shared, “PCR tests have high specificity and sensitivity. Antigen is only high specificity. It can have a false-negative rate of 15-20%.”

With this in mind, PCR testing is clearly the stronger test, but it may not always be the best choice. For post-exposure testing, Collins said, “PCR is more reliable, but it will take a few days to get back, so patients should quarantine until results.”

In the case of mass testing, the antigen test may be better because it acts as a monitoring system, and people are being tested regularly. “Antigen testing is fastest and least expensive. No lab is needed. Because you’re regular testing, you can overcome the sensitivity issue,” Dr. Cohen added.

Learn more about COVID testing and precautions to take by watching the conversation.

HealthFirst

Part of this channel

HealthFirst

Practice-ready solutions for dental and medical offices nationwide.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Why ECG device makers may stop rebuilding arrhythmia analysis from scratch

Why ECG device makers may stop rebuilding arrhythmia analysis from scratch

Monebo's Kinetic Software Library provides ectopic beat detection, QRS feature extraction, and heart rate and rhythm analysis for ECG devices. For ECG device engineering and regulatory teams, rhythm analysis could become a choice between building it and licensing it.

  • 01Fifty-one later FDA clearances trace their predicate lineage to Monebo's earlier libraries, a track record anyone evaluating the new one can check.

Nov 1, 2026

AI Takes Center Stage at AHA 2026. Experts Warn It Must Be Built for Everyone

AI Takes Center Stage at AHA 2026. Experts Warn It Must Be Built for Everyone

AI-enabled ECG, echocardiography and imaging studies are a major theme at the American Heart Association's Scientific Sessions 2026 in Chicago, November 6 to 9. A Frontiers in Cardiovascular Medicine policy brief led by Emory cardiologist Dr. Jose R. Medina-Inojosa argues precision cardiology must be designed with equity from inception. He says the biggest factor is not algorithm accuracy but the pathway from result to clinical action.

  • 01AHA 2026 late-breakers on AI include WATCH-LV, AI ECHO INSIGHT, PROVAR+ and LIFE-AI, all presented Monday, November 9.
  • 02Medina-Inojosa says equity from inception means training and validating on representative data and reporting subgroup performance before deployment.
  • 03Programs in Nigeria and Uganda show AI-ECG and AI-guided echo can extend cardiac care where specialists are scarce.

Nov 1, 2026

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Ambulatory surgery center volumes are projected to rise 24% over the next decade, with anesthesiology and gastroenterology shortages projected for 2027. That puts potential staffing constraints early in the growth period, so operators planning coverage may find the nearer 2027 date sets the pace.

  • 01A 24% ten-year forecast and a 9% forecast for 2023 to 2028 measure different windows; check the time frame and start year before putting either in a budget.
  • 02With about nine in ten ASCs at least partly physician-owned, a staffing gap could hit physician owners directly as clinicians and investors.

Oct 30, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512